Article info
Brief reports
Scarce vaccine supplies in an influenza pandemic should not be distributed randomly: reply to McLachlan
- Correspondence to Alistair Wardrope, The Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK; ajbwardrope1{at}sheffield.ac.uk
Citation
Scarce vaccine supplies in an influenza pandemic should not be distributed randomly: reply to McLachlan
Publication history
- Received April 23, 2012
- Revised June 6, 2012
- Accepted July 31, 2012
- First published August 28, 2012.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- On the random distribution of scarce doses of vaccine in response to the threat of an influenza pandemic: a response to Wardrope
- Love thy neighbour? Allocating vaccines in a world of competing obligations
- A proposed non-consequentialist policy for the ethical distribution of scarce vaccination in the face of an influenza pandemic
- Vaccine ethics: an ethical framework for global distribution of COVID-19 vaccines
- Ethical allocation of future COVID-19 vaccines
- Vaccine equity in COVID-19: a meta-narrative review
- Global access to COVID-19 vaccines: a scoping review of factors that may influence equitable access for low and middle-income countries
- What is the role of primary care in the COVID-19 vaccine roll-out and the barriers and facilitators to an equitable vaccine roll-out? A rapid scoping review of nine jurisdictions
- Towards a new model of global health justice: the case of COVID-19 vaccines
- A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review